AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33749041 — intervention group
Group type: EXPERIMENTAL
Intervention: DBB (Deproteinized Bovine Bone) with SA-H (Sandblasting + acid attack + immersion in 0.9% sodium chloride isotonic solution)
Number of subjects: 16
Study 33749041 — intervention group
Group type: EXPERIMENTAL
Intervention: DBB/BM (Deproteinized bovine bone associated with fresh autologous bone marrow) with SA (Sandblasting + acid attack)
Number of subjects: 16
Study 33749041 — intervention group
Group type: EXPERIMENTAL
Intervention: DBB/BM (Deproteinized bovine bone associated with fresh autologous bone marrow) with SA-H (Sandblasting + acid attack + immersion in 0.9% sodium chloride isotonic solution)
Number of subjects: 16
Study 34562434 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced sedentary behavior (SB) intervention group (n=31)
Number of subjects: 61
Study 34562434 — intervention group
Group type: COMPARATOR
Intervention: Increased physical activity levels control group (n=30)
Number of subjects: 61
Study 34226222 — intervention group
Group type: EXPERIMENTAL
Intervention: KTP intervention including 2-hour structured training sessions with procedure bundle and email reminders
Number of subjects: 32
Study 34226222 — intervention group
Group type: EXPERIMENTAL
Intervention: KTP intervention
Number of subjects: 32
Study 33720589 — intervention group
Group type: EXPERIMENTAL
Intervention: riamilovir
Number of subjects: 270
Study 33720589 — intervention group
Group type: EXPERIMENTAL
Intervention: riamilovir (3 times a day)
Number of subjects: 270
Study 33720589 — intervention group
Group type: EXPERIMENTAL
Intervention: riamilovir (other regimens)
Number of subjects: 270
Study 33703855 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal transradial access (dTRA)
Number of subjects: 204
Study 33703855 — intervention group
Group type: COMPARATOR
Intervention: Conventional transradial access (cTRA)
Number of subjects: 204
Study 33703855 — intervention group
Group type: EXPERIMENTAL
Intervention: Both dTRA and cTRA
Number of subjects: 204
Study 34105256 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body EMS (n=48)
Number of subjects: 134
Study 34105256 — intervention group
Group type: EXPERIMENTAL
Intervention: Part-body EMS (n=42)
Number of subjects: 134
Study 34105256 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=44)
Number of subjects: 134
Study 32811664 — intervention group
Group type: EXPERIMENTAL
Intervention: Barrel Hoop plate (BHP)
Number of subjects: 36
Study 32811664 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterolateral plate (PP)
Number of subjects: 36
Study 32811664 — intervention group
Group type: COMPARATOR
Intervention: Anterolateral plate (AP)
Number of subjects: 36
Study 34949702 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon drain
Number of subjects: 267
Study 34949702 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 267
Study 32068854 — intervention group
Group type: EXPERIMENTAL
Intervention: CMV shedding prevalence in children's saliva
Number of subjects: 1770
Study 32068854 — intervention group
Group type: EXPERIMENTAL
Intervention: Viral load of CMV in saliva
Number of subjects: 1770
Study 32068854 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors for higher viral load
Number of subjects: 1770
Study 32068854 — intervention group
Group type: EXPERIMENTAL
Intervention: CMV awareness among parents
Number of subjects: 1770
Study 35701732 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief hope intervention (BHI)
Number of subjects: 72
Study 35701732 — intervention group
Group type: COMPARATOR
Intervention: Control group (customized pre-dialysis education class)
Number of subjects: 72
Study 32208045 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-Assisted Self-Help (TASH) intervention (8 self-help booklets plus up to 14 counseling telephone calls)
Number of subjects: 0
Study 32208045 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-Assisted Self-Help (TASH) intervention
Number of subjects: 0
Study 36444740 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 150 mg
Number of subjects: 29
Study 36444740 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 33409591 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential romosozumab-to-alendronate treatment
Number of subjects: 1
Study 33409591 — intervention group
Group type: COMPARATOR
Intervention: Alendronate alone
Number of subjects: 1
Study 32371747 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Simulation (VS)
Number of subjects: 60
Study 32371747 — intervention group
Group type: COMPARATOR
Intervention: Multimedia Lecture
Number of subjects: 60
Study 35728900 — intervention group
Group type: EXPERIMENTAL
Intervention: Ava-bracelet measuring respiratory rate (RR), heart rate (HR), HR variability (HRV), wrist-skin temperature (WST), and skin perfusion
Number of subjects: 1163
Study 35728900 — intervention group
Group type: EXPERIMENTAL
Intervention: Long short-term memory (LSTM) based recurrent neural network (RNN) algorithm
Number of subjects: 1163
Study 36174365 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS combined with cognitive training (CT)
Number of subjects: 25
Study 36174365 — intervention group
Group type: COMPARATOR
Intervention: Sham-tDCS combined with cognitive training (CT)
Number of subjects: 25
Study 36174365 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 25
Study 36174365 — intervention group
Group type: COMPARATOR
Intervention: Sham-tDCS
Number of subjects: 25
Study 33655526 — intervention group
Group type: EXPERIMENTAL
Intervention: Circuit-based physical activity intervention
Number of subjects: 193
Study 33655526 — intervention group
Group type: EXPERIMENTAL
Intervention: Circuit-based physical activity intervention (girls)
Number of subjects: 193
Study 33655526 — intervention group
Group type: EXPERIMENTAL
Intervention: Circuit-based physical activity intervention (obesity)
Number of subjects: 193
Study 33655526 — intervention group
Group type: COMPARATOR
Intervention: TAU (PE class as usual)
Number of subjects: 193
Study 32672427 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal-replacement therapy initiation timing
Number of subjects: 0
Study 36169069 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-filled consent form
Number of subjects: 0
Study 36169069 — intervention group
Group type: COMPARATOR
Intervention: Standard hand-written consent form
Number of subjects: 0
Study 33188966 — intervention group
Group type: EXPERIMENTAL
Intervention: Various treatments for lateral ankle sprain
Number of subjects: 74
Study 33188966 — intervention group
Group type: COMPARATOR
Intervention: Statistical significance reporting
Number of subjects: 74
Study 32665265 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental priming (EP)
Number of subjects: 52
Study 32665265 — intervention group
Group type: COMPARATOR
Intervention: Unprimed group
Number of subjects: 52
Study 32990494 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling intervention over 4 months
Number of subjects: 85
Study 36213929 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention (5 days a week for 60 min each for 12 weeks)
Number of subjects: 60
Study 36213929 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention
Number of subjects: 60
Study 36175048 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg/d aspirin
Number of subjects: 12815
Study 36175048 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12815
Study 34547471 — intervention group
Group type: EXPERIMENTAL
Intervention: MB/IPL/PDT sessions (group A)
Number of subjects: 80
Study 34547471 — intervention group
Group type: EXPERIMENTAL
Intervention: IPL sessions (group B)
Number of subjects: 80
Study 34547471 — intervention group
Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 80
Study 35901105 — intervention group
Group type: EXPERIMENTAL
Intervention: Game-based high-intensity interval training (Game-HIIT) program
Number of subjects: 42
Study 35901105 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional game-based structured aerobic exercise (GameSAE) program
Number of subjects: 42
Study 35901105 — intervention group
Group type: COMPARATOR
Intervention: Non-treatment control group (regular physical activity)
Number of subjects: 42
Study 33468302 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonographic examination using a 5 MHz linear transducer
Number of subjects: 54
Study 33468302 — intervention group
Group type: COMPARATOR
Intervention: Radiographs as the reference standard method
Number of subjects: 54
Study 36006040 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrarectal povidone‐iodine cleansing plus formalin disinfection of the needle tip
Number of subjects: 1256
Study 36006040 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1256
Study 34275593 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (25 to 100 mg/day, flexibly titrated by week 6)
Number of subjects: 149
Study 34275593 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study 34275593 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 149
Study 33879183 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Engage (values‐oriented behaviors)
Number of subjects: 90
Study 33879183 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Openness (acceptance and cognitive defusion)
Number of subjects: 90
Study 33879183 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Awareness (being present and aware)
Number of subjects: 90
Study 33891569 — intervention group
Group type: EXPERIMENTAL
Intervention: Neem capsules (50 mg of neem-leaf extract, twice a day for 28 days)
Number of subjects: 190
Study 33891569 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules (twice a day for 28 days)
Number of subjects: 190
Study 33891569 — intervention group
Group type: EXPERIMENTAL
Intervention: Neem capsules
Number of subjects: 190
Study 33891569 — intervention group
Group type: COMPARATOR
Intervention: Neem capsules and Placebo
Number of subjects: 190
Study 35551580 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 2000 IU/D for 12 weeks
Number of subjects: 90
Study 34172012 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic formula
Number of subjects: 153
Study 34172012 — intervention group
Group type: EXPERIMENTAL
Intervention: Prebiotics
Number of subjects: 153
Study 34172012 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsupplemented formula
Number of subjects: 153
Study 34172012 — intervention group
Group type: COMPARATOR
Intervention: Vaginal birth (reference group)
Number of subjects: 153
Study 34172012 — intervention group
Group type: COMPARATOR
Intervention: C-section birth
Number of subjects: 153
Study 36379186 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacituzumab govitecan (SG)
Number of subjects: 419
Study 36379186 — intervention group
Group type: COMPARATOR
Intervention: Treatment of physician's choice (TPC)
Number of subjects: 419
Study 34957020 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy-focused structured education program (SSEP)
Number of subjects: 0
Study 34957020 — intervention group
Group type: COMPARATOR
Intervention: Routine education
Number of subjects: 0
Study 34023029 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-dialytic cycling (exercise group)
Number of subjects: 101
Study 34023029 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 101
Study 35726893 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP of 8 mbar
Number of subjects: 382
Study 35726893 — intervention group
Group type: COMPARATOR
Intervention: ZEEP
Number of subjects: 382
Study 32000093 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT), 12 sessions
Number of subjects: 99
Study 32000093 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 99
Study 37670008 — intervention group
Group type: EXPERIMENTAL
Intervention: Stationary-bike exercise
Number of subjects: 0
Study 37670008 — intervention group
Group type: COMPARATOR
Intervention: Resting control condition
Number of subjects: 0
Study 34446390 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 4012
Study 34446390 — intervention group
Group type: COMPARATOR
Intervention: Prasugrel
Number of subjects: 4012
Study 34446390 — intervention group
Group type: EXPERIMENTAL
Intervention: Low eGFR
Number of subjects: 4012
Study 34446390 — intervention group
Group type: COMPARATOR
Intervention: Ticagrelor vs Prasugrel
Number of subjects: 4012
Study 34839074 — intervention group
Group type: EXPERIMENTAL
Intervention: CCRT
Number of subjects: 270
Study 34839074 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT
Number of subjects: 270
Study 34839074 — intervention group
Group type: COMPARATOR
Intervention: Active control
Number of subjects: 270
Study 33397420 — intervention group
Group type: EXPERIMENTAL
Intervention: Current alcohol use (any amount)
Number of subjects: 420
Study 33397420 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem drinking behavior (identified by AUDIT)
Number of subjects: 420
Study 33397420 — intervention group
Group type: EXPERIMENTAL
Intervention: Hazardous drinking
Number of subjects: 420
Study 33397420 — intervention group
Group type: EXPERIMENTAL
Intervention: Active alcohol dependent behavior
Number of subjects: 420
Study 33397420 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictors of maternal alcohol use
Number of subjects: 420
Study 35000470 — intervention group
Group type: EXPERIMENTAL
Intervention: Stellarex low-dose paclitaxel drug-coated balloon (DCB)
Number of subjects: 0
Study 35000470 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty (PTA)
Number of subjects: 0
Study 32369162 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoked cannabis administration (50.6 mg THC)
Number of subjects: 20
Study 32369162 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaporized cannabis administration (50.6 mg THC)
Number of subjects: 20
Study 32369162 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cannabis administration (50.6 mg THC)
Number of subjects: 20
Study 32369162 — intervention group
Group type: EXPERIMENTAL
Intervention: All routes of administration
Number of subjects: 20
Study 32369162 — intervention group
Group type: EXPERIMENTAL
Intervention: THC-glucuronide
Number of subjects: 20
Study 32369162 — intervention group
Group type: EXPERIMENTAL
Intervention: THCCOOH, THC-glucuronide, and THCVCOOH
Number of subjects: 20
Study 36096134 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous gastric feeding (CGF) over 2 hours
Number of subjects: 32
Study 36096134 — intervention group
Group type: COMPARATOR
Intervention: Bolus feeding (BF) over 15-30 minutes
Number of subjects: 32
Study 33736940 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (50‐54 Gy to the mediastinum using intensity‐modulated radiation therapy or proton beam therapy)
Number of subjects: 314
Study 33736940 — intervention group
Group type: COMPARATOR
Intervention: Surveillance
Number of subjects: 314
Study 33736940 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 314
Study 32731936 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized clinical trials (RCTs)
Number of subjects: 0
Study 32731936 — intervention group
Group type: COMPARATOR
Intervention: Common sense and clinical observation
Number of subjects: 0
Study 35122323 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based educational intervention (self-education program with video and training questions)
Number of subjects: 284
Study 35122323 — intervention group
Group type: COMPARATOR
Intervention: Non-education group (no educational intervention)
Number of subjects: 284
Study 33047127 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg nicotine/mL cherry
Number of subjects: 39
Study 33047127 — intervention group
Group type: EXPERIMENTAL
Intervention: 18 mg/mL cherry
Number of subjects: 39
Study 33047127 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg/mL chocolate
Number of subjects: 39
Study 33047127 — intervention group
Group type: EXPERIMENTAL
Intervention: 18 mg/mL chocolate
Number of subjects: 39
Study 33047127 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 39
Study 35446902 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron + Folic Acid + Counselling on Locally Available Dietary Intervention (IFA+LAD arm)
Number of subjects: 496
Study 35446902 — intervention group
Group type: COMPARATOR
Intervention: Iron + Folic Acid (IFA arm)
Number of subjects: 496
Study 33210434 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/mL triamcinolone acetonide (TA)
Number of subjects: 105
Study 33210434 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/mL triamcinolone acetonide (TA)
Number of subjects: 105
Study 33210434 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg/mL triamcinolone acetonide (TA)
Number of subjects: 105
Study 33210434 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (NS)
Number of subjects: 105
Study 35791616 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea leaf extract (GTE) tablet
Number of subjects: 0
Study 35791616 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 0
Study 35931636 — intervention group
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 + IIV4/PPV23 group
Number of subjects: 1152
Study 35931636 — intervention group
Group type: COMPARATOR
Intervention: SARS-CoV-2 vaccine group
Number of subjects: 1152
Study 35931636 — intervention group
Group type: COMPARATOR
Intervention: IIV4/PPV23 group
Number of subjects: 1152
Study 33273290 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteoporosis outreach program
Number of subjects: 10934
Study 33273290 — intervention group
Group type: COMPARATOR
Intervention: No outreach
Number of subjects: 10934
Study 35390511 — intervention group
Group type: EXPERIMENTAL
Intervention: Amantadine 200 mg per day for 14 days
Number of subjects: 200
Study 35390511 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 32820003 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiriva Respimat (2.5 μg twice a day) in combination with ICS/LABA
Number of subjects: 0
Study 32820003 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiriva HandiHaler (18 μg once a day) in combination with ICS/LABA
Number of subjects: 0
Study 33913348 — intervention group
Group type: EXPERIMENTAL
Intervention: Food and Nutrition Education Program with Sensory and Cognitive Exercises (PESC), consisting of four weekly workshops.
Number of subjects: 60
Study 33913348 — intervention group
Group type: COMPARATOR
Intervention: Control group (no workshops), evaluated twice with a one-month interval.
Number of subjects: 60
Study 34994286 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine plus low dose contraceptive
Number of subjects: 100
Study 34994286 — intervention group
Group type: COMPARATOR
Intervention: Low dose contraceptive alone
Number of subjects: 100
Study 32135382 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehabilitation Program (PP)
Number of subjects: 70
Study 32135382 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (C)
Number of subjects: 70
Study 36162791 — intervention group
Group type: EXPERIMENTAL
Intervention: Active network-tDCS (n=19)
Number of subjects: 38
Study 36162791 — intervention group
Group type: COMPARATOR
Intervention: Sham network-tDCS (n=19)
Number of subjects: 38
Study 36162791 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Active and Sham)
Number of subjects: 38
Study 36162791 — intervention group
Group type: EXPERIMENTAL
Intervention: Active network-tDCS
Number of subjects: 38
Study 33246064 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam (2.5 mg)
Number of subjects: 17
Study 33246064 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 33201202 — intervention group
Group type: EXPERIMENTAL
Intervention: Care bundle including early intravenous nitrate boluses, management of precipitating factors, and moderate dose of intravenous diuretics (median 27.0 mg of intravenous nitrates in the first 4 hours).
Number of subjects: 503
Study 33201202 — intervention group
Group type: EXPERIMENTAL
Intervention: Care bundle (intervention group).
Number of subjects: 503
Study 33201202 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care).
Number of subjects: 503
Study 36111429 — intervention group
Group type: EXPERIMENTAL
Intervention: Erenumab (ERE) 140 mg
Number of subjects: 65
Study 36111429 — intervention group
Group type: EXPERIMENTAL
Intervention: Galcanezumab (GMB) 240 mg
Number of subjects: 65
Study 34169412 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness intervention
Number of subjects: 3519
Study 34169412 — intervention group
Group type: COMPARATOR
Intervention: Active control program (relaxation)
Number of subjects: 3519
Study 34169412 — intervention group
Group type: COMPARATOR
Intervention: Inactive control group
Number of subjects: 3519
Study 32791965 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-anesthesia best possible medication history (PA-BPMH) performed by a clinical pharmacist
Number of subjects: 455
Study 35593290 — intervention group
Group type: EXPERIMENTAL
Intervention: Special platelet-rich plasma tubes centrifuged at 3500 rpm
Number of subjects: 30
Study 35593290 — intervention group
Group type: EXPERIMENTAL
Intervention: Ordinary laboratory tubes centrifuged at 1000 rpm
Number of subjects: 30
Study 35593290 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 30
Study 33066980 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetotherapy (15 sessions of 20 minutes, 5 consecutive days per week)
Number of subjects: 19
Study 32267856 — intervention group
Group type: EXPERIMENTAL
Intervention: Arithmetic mean
Number of subjects: 49
Study 32267856 — intervention group
Group type: EXPERIMENTAL
Intervention: Hölder mean M0.2
Number of subjects: 49
Study 32267856 — intervention group
Group type: EXPERIMENTAL
Intervention: Geometric mean
Number of subjects: 49
Study 32267856 — intervention group
Group type: EXPERIMENTAL
Intervention: Winsorized mean (0.1 cut-off)
Number of subjects: 49
Study 35572833 — intervention group
Group type: EXPERIMENTAL
Intervention: Doctor-nurse-patient integrated nursing management
Number of subjects: 120
Study 35572833 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing
Number of subjects: 120
Study 35572833 — intervention group
Group type: EXPERIMENTAL
Intervention: Hessian matrix enhanced filter segmentation algorithm
Number of subjects: 120
Study 35572833 — intervention group
Group type: COMPARATOR
Intervention: Conventional CTA
Number of subjects: 120